Search research articles
Contact Us
Filters
Showing results (41-50 of 88) with videos related to
Page
of 9
Sort By:
The Journal of Pharmacology and Experimental Therapeutics
|
April 1, 1993
Examination of the neurochemical substrates mediating the motivational effects of opioids: role of the mesolimbic dopamine system and D-1 vs. D-2 dopamine receptors
T S Shippenberg, R Bals-Kubik, A Herz
Pharmacology & Therapeutics
|
September 18, 2007
Dynorphin and the pathophysiology of drug addiction
T S Shippenberg, A Zapata, V I Chefer
Cellular and Molecular Life Sciences : CMLS
|
October 18, 2011
The dynorphin/κ-opioid receptor system and its role in psychiatric disorders
H A Tejeda, T S Shippenberg, R Henriksson
Pharmacology, Biochemistry, and Behavior
|
January 1, 1981
The effects of opiate antagonists on the discriminative stimulus properties of ethanol
H L Altshuler, E Applebaum, T S Shippenberg
Annals of the New York Academy of Sciences
|
July 23, 1999
Modulation of cocaine-induced sensitization by kappa-opioid receptor agonists. Role of the nucleus accumbens and medial prefrontal cortex
V Chefer, A C Thompson, T S Shippenberg
European Journal of Pharmacology
|
October 24, 1994
Evidence that nor-binaltorphimine can function as an antagonist at multiple opioid receptor subtypes
R Spanagel, O F Almeida, T S Shippenberg
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
October 1, 1988
Beta-endorphin-(1-27) is a naturally occurring antagonist of the reinforcing effects of opioids
R Bals-Kubik, A Herz, T S Shippenberg
European Journal of Pharmacology
|
April 4, 1996
Role of delta-opioid receptors in mediating the aversive stimulus effects of morphine withdrawal in the rat
M Funada, C G Schutz, T S Shippenberg
European Journal of Pharmacology
|
October 19, 1993
Inhibition of cocaine-induced sensitization by the delta-opioid receptor antagonist naltrindole
C Heidbreder, S R Goldberg, T S Shippenberg
Synapse (New York, N.Y.)
|
July 1, 1993
Long lasting changes in morphine-induced mesolimbic dopamine release after chronic morphine exposure
R Spanagel, O F Almeida, T S Shippenberg
Page
of 9
Search research articles
Search
Showing results (41-50 of 88) with videos related to
Sort By:
Page
of 9
The Journal of Pharmacology and Experimental Therapeutics
|
April 1, 1993
Examination of the neurochemical substrates mediating the motivational effects of opioids: role of the mesolimbic dopamine system and D-1 vs. D-2 dopamine receptors
T S Shippenberg, R Bals-Kubik, A Herz
Pharmacology & Therapeutics
|
September 18, 2007
Dynorphin and the pathophysiology of drug addiction
T S Shippenberg, A Zapata, V I Chefer
Cellular and Molecular Life Sciences : CMLS
|
October 18, 2011
The dynorphin/κ-opioid receptor system and its role in psychiatric disorders
H A Tejeda, T S Shippenberg, R Henriksson
Pharmacology, Biochemistry, and Behavior
|
January 1, 1981
The effects of opiate antagonists on the discriminative stimulus properties of ethanol
H L Altshuler, E Applebaum, T S Shippenberg
Annals of the New York Academy of Sciences
|
July 23, 1999
Modulation of cocaine-induced sensitization by kappa-opioid receptor agonists. Role of the nucleus accumbens and medial prefrontal cortex
V Chefer, A C Thompson, T S Shippenberg
European Journal of Pharmacology
|
October 24, 1994
Evidence that nor-binaltorphimine can function as an antagonist at multiple opioid receptor subtypes
R Spanagel, O F Almeida, T S Shippenberg
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
October 1, 1988
Beta-endorphin-(1-27) is a naturally occurring antagonist of the reinforcing effects of opioids
R Bals-Kubik, A Herz, T S Shippenberg
European Journal of Pharmacology
|
April 4, 1996
Role of delta-opioid receptors in mediating the aversive stimulus effects of morphine withdrawal in the rat
M Funada, C G Schutz, T S Shippenberg
European Journal of Pharmacology
|
October 19, 1993
Inhibition of cocaine-induced sensitization by the delta-opioid receptor antagonist naltrindole
C Heidbreder, S R Goldberg, T S Shippenberg
Synapse (New York, N.Y.)
|
July 1, 1993
Long lasting changes in morphine-induced mesolimbic dopamine release after chronic morphine exposure
R Spanagel, O F Almeida, T S Shippenberg
Page
of 9